Vascudyne

Plano, United States

Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.

$4.0M raised

Jun 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vascudyne raised?

Vascudyne has raised $4.0M in total funding. The most recent round was Grant. The last funding was announced in June 2025.

Who are Vascudyne's investors?

Vascudyne's investors include Congressionally Directed Medical Research Programs, Regenerative Medicine Minnesota.

Where is Vascudyne headquartered?

Vascudyne is headquartered in Plano, United States.

What does Vascudyne do?

Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.

What stage is Vascudyne at?

Vascudyne is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 1, 2025.

MLA

"Vascudyne — Funding & Investors." VCBacked, June 1, 2025, https://www.vcbacked.co/company/vascudyne. Accessed July 2, 2026.

APA

VCBacked. (2025). Vascudyne — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vascudyne

Wikipedia (cite web)

{{cite web |title=Vascudyne — Funding & Investors |url=https://www.vcbacked.co/company/vascudyne |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 1, 2025.